Citation: Hidetaka Hamasaki, Yasuteru Hamasaki. Nuts for Physical Health and Fitness: A Review[J]. AIMS Medical Science, 2017, 4(4): 441-455. doi: 10.3934/medsci.2017.4.441
[1] | Chenqian Li, Jun Liu, Jinshan Tang . Simultaneous segmentation and classification of colon cancer polyp images using a dual branch multi-task learning network. Mathematical Biosciences and Engineering, 2024, 21(2): 2024-2049. doi: 10.3934/mbe.2024090 |
[2] | Yun Jiang, Jie Chen, Wei Yan, Zequn Zhang, Hao Qiao, Meiqi Wang . MAG-Net : Multi-fusion network with grouped attention for retinal vessel segmentation. Mathematical Biosciences and Engineering, 2024, 21(2): 1938-1958. doi: 10.3934/mbe.2024086 |
[3] | Feiyu Chen, Haiping Ma, Weijia Zhang . SegT: Separated edge-guidance transformer network for polyp segmentation. Mathematical Biosciences and Engineering, 2023, 20(10): 17803-17821. doi: 10.3934/mbe.2023791 |
[4] | Zhigao Zeng, Cheng Huang, Wenqiu Zhu, Zhiqiang Wen, Xinpan Yuan . Flower image classification based on an improved lightweight neural network with multi-scale feature fusion and attention mechanism. Mathematical Biosciences and Engineering, 2023, 20(8): 13900-13920. doi: 10.3934/mbe.2023619 |
[5] | Rongrong Bi, Chunlei Ji, Zhipeng Yang, Meixia Qiao, Peiqing Lv, Haiying Wang . Residual based attention-Unet combing DAC and RMP modules for automatic liver tumor segmentation in CT. Mathematical Biosciences and Engineering, 2022, 19(5): 4703-4718. doi: 10.3934/mbe.2022219 |
[6] | Yalong Yang, Zhen Niu, Liangliang Su, Wenjing Xu, Yuanhang Wang . Multi-scale feature fusion for pavement crack detection based on Transformer. Mathematical Biosciences and Engineering, 2023, 20(8): 14920-14937. doi: 10.3934/mbe.2023668 |
[7] | Hong'an Li, Man Liu, Jiangwen Fan, Qingfang Liu . Biomedical image segmentation algorithm based on dense atrous convolution. Mathematical Biosciences and Engineering, 2024, 21(3): 4351-4369. doi: 10.3934/mbe.2024192 |
[8] | Zhenyin Fu, Jin Zhang, Ruyi Luo, Yutong Sun, Dongdong Deng, Ling Xia . TF-Unet:An automatic cardiac MRI image segmentation method. Mathematical Biosciences and Engineering, 2022, 19(5): 5207-5222. doi: 10.3934/mbe.2022244 |
[9] | Tong Shan, Jiayong Yan, Xiaoyao Cui, Lijian Xie . DSCA-Net: A depthwise separable convolutional neural network with attention mechanism for medical image segmentation. Mathematical Biosciences and Engineering, 2023, 20(1): 365-382. doi: 10.3934/mbe.2023017 |
[10] | Chaofan Li, Kai Ma . Entity recognition of Chinese medical text based on multi-head self-attention combined with BILSTM-CRF. Mathematical Biosciences and Engineering, 2022, 19(3): 2206-2218. doi: 10.3934/mbe.2022103 |
Nowadays there are always various communicable diseases, such as malaria, dengue fever, HIV/AIDS, Zika virus, and COVID-19, which impair the health of people around the globe [2]. Especially, as of now, COVID-19 has killed more than 4 million people and is still prevailing in many countries over the world. Since Covid-19 was first identified in January 2020, thousands of mutations have been detected [34]. Moreover, it has been reported that various new strains of COVID-19 are considered as more dangerous than the original virus. In fact, the variation of pathogens is very common in epidemiology, we can refer to [4] for the instance of the mutation of influenza virus. Besides, Dengue fever is one of the most typical vector-borne infectious disease prevailing in the tropical and subtropical areas. Usually, the fever is caused by five different serotypes (DEN I-IV) and the corresponding fatality rates of these serotypes are dramatically different. This means that a person living in an endemic area might be facing the risk of infection from five distinct serotypes, and a individual who recovered form one of the serotypes could get permanent immunity to itself and only temporary cross-immune against the others. In recent years, mathematical model increasingly become a effective tool in the investigation of the spread of epidemics. With the aid of proper analysis for the mathematical models, we can better understand the transmission mechanism of infectious diseases and then take appropriate prevention and control measures to combat the diseases. In fact, the researches of epidemic dynamics models involving multi-strain interactions have attracted considerable attention of many scholars. Baba et al. [4] studied a two-strain model containing vaccination for both strains. Cai et al. [6] studied a two-strain model including vaccination, and analyzed the interaction between the strains under the vaccination theme. A class of multi-chain models with discrete time delays, moreover, is considered in the case of temporary immunity and multiple cross immunity by Bauer et al. [5]. For more literatures corresponding to pathogens with multiple strains, we can refer to [1,8,24,30,33,39] and the references.
In reality, accumulating empirical evidence shows that seasonal factors can affect the host-pathogen interactions [3], and the incidence of many infectious diseases fluctuates over time, often with a cyclical pattern(see, e.g., [16,31,37]). In addition, Yang, et al [35] found that temperature and relative humidity were mainly the driving factors on COVID-19 transmission. It is therefore necessary to consider infectious disease models with time-dependent parameters. Martcheva et al. [24] considered a class of multi-chain models with time-periodic coefficients. Precisely speaking, they presented sufficient conditions to guarantee the coexistence of the two-strain, and further proved that competitive exclusion would occur only when the transmission rates on each chain are linearly correlated.
At the same time, it is noticed that the resources, humidity and temperature are not uniformly distributed in space, then spatial heterogeneity should not be ignored a practical epidemiological model. From the point of view of model's rationalization, the main parameters, such as infection rate and recovery rate, should be intrinsically spatially dependent. Taking into consideration both the spatial heterogeneity of the environment and the impact of individual movement on disease transmission, Tuncer et al. [33] proposed the following two-strain model:
{∂S(x,t)∂t=dSΔS(x,t)−(β1(x)I1(x,t)+β2(x)I2(x,t))S(x,t)S(x,t)+I1(x,t)+I2(x,t) +r1(x,t)I1(x,t)+r2(x,t)I2(x,t),∂I1(x,t)∂t=d1ΔI1(x,t)+β1(x)S(x,t)I1(x,t)S(x,t)+I1(x,t)+I2(x,t)−r1(x,t)I1(x,t),∂I2(x,t)∂t=d2ΔI2(x,t)+β2(x)S(x,t)I2(x,t)S(x,t)+I1(x,t)+I2(x,t)−r2(x,t)I2(x,t). | (1.1) |
Furthermore, Acklehd et al. [1] studied a model with bilinear incidence, the results showed that the spatial heterogeneity facilitated the coexistence of strains. Taking into account alternation of seasons, Peng et al. [29] studied a reaction-diffusion SIS model, in which the disease transmission rate and recovery rate are all spatial-dependent and temporally periodic. The results show that temporal heterogeneity have little effect on the extinction and persistence of the diseases, nevertheless, the combination of temporal and spatial heterogeneity would increase the duration of the disease.
It is well known that the incubation period exist commonly in most infectious diseases, and the length of the incubation periods corresponding to different diseases are often different. We can refer Leung [19] for more information about the difference of the incubation period of COVID-19 between various different variants. During the incubation period, random movements of individuals can give rise to nonlocal effects, precisely speaking, the rate of gaining infectious individuals at current position at the present time actually depends on the infections at all possible locations and all possible previous times. This nonlocal interaction will affect the global dynamic behavior of the solutions [7,13], traveling wave phenomena [14], etc. Guo et al. [12] studied the threshold dynamics of a reaction-diffusion model with nonlocal effects. In particular, Zhao et al. [38] considered the threshold dynamics of a model with fixed latent period on the basis of model (1.1). In particular, when Ri0=1 and the infection rate is assumed to be strictly positive, they studied the threshold dynamics of the model by constructing the upper control system.
Due to the individual difference in age, nutrition, lifestyle and health status, there are significant difference in the immunity among different individuals [27]. This further lead to the difference of incubation periods in different individuals. As McAloon, et al. [27] points out, it is critically important to understand the variation in the distribution within the population. Thus, the fixed incubation period is not always an ideal description for most diseases. Takeuchi et al. [32] considered a vector-borne SIR infectious disease model with distributed time delay. Zhao et al. [39] studied a two-group reaction-diffusion model with distributed delay. In [39], the recovered individuals are assumed to be lifelong immune to the disease. However, this assumption is not suitable for all epidemics. Then it is very necessary to establish and analysis a SIRS model involving aforementioned various factors, and thus to further improve the existing relevant research. The purpose of this paper is to investigate the threshold dynamics of a two-strain SIRS epidemic model with distributed delay and spatiotemporal heterogeneity.
The remainder of this paper is organized as follows. In the next section, we derive the model and show its well-posedness. In section 3, we established the threshold dynamics for the system in term of the basic reproduction number Ri0 and the invasion number ˆRi0(i=1,2) for each strain i. At the end of the current paper, a brief but necessary discussion is presented to show some epidemiological implications of this study.
In this section, we propose a time-periodic two-strain SIRS model with distributed delay and spatiotemporal heterogeneity, and further analyze some useful properties of the solutions of the model.
Let Ω∈Rn denote the spatial habitat with smooth boundary ∂Ω. We suppose that only one mutant can appear in a pathogen, and a susceptible individual can only be infected by one virus strain. Denote the densities of the two different infectious classes with infection age a≥0 and at position x, and time t by E1(x,a,t) and E2(x,a,t), respectively. By a standard argument on structured population and spatial diffusion (see e.g., [28]), we obtain
{(∂∂t+∂∂a)Ei(x,a,t)=DiΔEi−(δi(x,a,t)+ri(x,a,t)+d(x,t))Ei(x,a,t), x∈Ω, a>0, t>0∂Ei(x,a,t)∂n=0, x∈∂Ω, a>0, t>0,i=1,2, | (2.1) |
where d(x,t) is the natural death rate at location x and time t; ri(x,a,t) and δi(x,a,t) represent the recovery rates and mortality rates induced by the disease of the i-th infectious classes with infection age a≥0 at position x and time t; the constants Di denote the diffusion rates of the i-th infectious class for i=1,2. We divide the population into six compartments: the susceptible group S(x,t), two latent groups Li(x,t), two infective groups Ii(x,t), and the recovered group R(x,t), i=1,2. Let N(x,t)=S(x,t)+∑i=1,2(Li(x,t)+Ii(x,t))+R(x,t). We assume that only a portion of recovered individuals would be permanently immune to the virus. Let α(x,a,t) be the loss of immunity rate with infection age a≥0 at position x and time t. In order to simplify the model reasonably, we further suppose that
δi(x,a,t)=δi(x,t), ri(x,a,t)=ri(x,t), α(x,a,t)=α(x,t), ∀x∈Ω, a,t≥0, i=1,2. |
On account of the individual differences of the incubation period among the different individuals, infections individuals of the i-th population be capable of infecting others until after a possible infection age a∈(0,τi], where the positive constant τi is the maximum incubation period of i-th strain, i=1,2. Let fi(r)dr denote the probability of becoming into the individuals who are capable of infecting others between the infection age r and r+dr, then Fi(a)=∫a0fi(r)dr represents the probability of turning into the individuals with infecting others before the infection age a for i=1,2. It is clear that Fi(a)≥0 for a∈(0,τi), Fi(a)≡1 for a∈[τi,+∞), i=1,2, and
Li(x,t)=∫τi0(1−Fi(a))Ei(x,a,t)da,Ii(x,t)=∫τi0Fi(a)Ei(x,a,t)da+∫+∞τiEi(x,a,t)da, i=1,2. | (2.2) |
Let
Ii,1(x,t)=∫τi0Fi(a)Ei(x,a,t)da, Ii,2(x,t)=∫+∞τiEi(x,a,t)da. |
It then follows that
∂Li(x,t)∂t=DiΔLi(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Li(x,t)−∫τi0fi(a)Ei(x,a,t)da+Ei(x,0,t), |
and
∂Ii,1(x,t)∂t=DiΔIi,1(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Ii,1(x,t)+∫τi0fi(a)Ei(x,a,t)da−Ei(x,τi,t), |
∂Ii,2(x,t)∂t=DiΔIi,2(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Ii,2(x,t)+Ei(x,τi,t)−Ei(x,∞,t), |
where i=1,2. Biologically, we assume Ei(x,∞,t)=0(i=1,2). Then we have
∂Ii(x,t)∂t=DiΔIi(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Ii(x,t)+∫τi0fi(a)Ei(x,a,t)da. |
Denote the infection rate by βi(x,t)≥0. Due to the fact that the contact of susceptible and infectious individuals yields the new infected individuals, we take Ei(x,0,t) as follows:
Ei(x,0,t)=βi(x,t)S(x,t)Ii(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t), i=1,2. |
In the absence of disease, moreover, we suppose that the evolution of the population density follows the following equation:
∂N(x,t)∂t=DNΔN(x,t)+μ(x,t)−d(x,t)N(x,t), |
where d(x,t) is the natural death rate, μ(x,t) is the recruiting rate, and DN denotes the diffusion rate. In conclusion, the disease dynamics is expressed by the following system:
{∂S(x,t)∂t=DSΔS(x,t)+μ(x,t)−d(x,t)S(x,t)+α(x,t)R(x,t)−β1(x,t)S(x,t)I1(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t)−β2(x,t)S(x,t)I2(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t),∂Li(x,t)∂t=DiΔLi(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Li(x,t)+βi(x,t)S(x,t)Ii(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t)−∫τi0fi(a)Ei(x,a,t)da,∂Ii(x,t)∂t=DiΔIi(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Ii(x,t)+∫τi0fi(a)Ei(x,a,t)da,∂R(x,t)∂t=DRΔR(x,t)+r1(x,t)(L1(x,t)+I1(x,t))+r2(x,t)(L2(x,t)+I2(x,t))−d(x,t)R(x,t)−α(x,t)R(x,t), i=1,2. | (2.3) |
We make the following basic assumption:
(H) DS,Di,DR>0, i=1,2, the functions d(x,t),μ(x,t),α(x,t),βi(x,t),δi(x,t),ri(x,t) are Hölder continuous and nonnegative nontrivial on ˉΩ×R, and periodic in time t with the same period T>0. Moreover, d(x,t)>0, x∈∂Ω, t>0.
For the sake of simplicity, we let hi(x,t)=δi(x,t)+ri(x,t)+d(x,t), i=1,2. In order to determine Ei(x,a,t), let Vi(x,a,ξ)=Ei(x,a,a+ξ), ∀ξ≥0, i=1,2. By a similar idea as that in [36], we have
{∂Vi(x,a,ξ)∂a=DiΔVi(x,a,ξ)−hi(x,t)Vi(x,a,ξ),Vi(x,0,ξ)=Ei(x,0,ξ)=βi(x,ξ)S(x,ξ)Ii(x,ξ)S(x,ξ)+I1(x,ξ)+I2(x,ξ)+R(x,ξ), i=1,2. |
Let Γi(x,y,t,s) with x,y∈Ω and t>s≥0 be the fundamental solution associated with the partial differential operator ∂t−DiΔ−hi(x,t)(i=1,2). Then we have
Vi(x,a,ξ)=∫ΩΓi(x,y,ξ+a,ξ)βi(y,ξ)S(y,ξ)Ii(y,ξ)S(y,ξ)+I1(y,ξ)+I2(y,ξ)+R(y,ξ)dy. | (2.4) |
According to the periodicity of hi and βi, Γi(x,y,t,s) is periodic, that is, Γi(x,y,t+T,s+T)=Γi(x,y,t,s), ∀x,y∈Ω, t>s≥0, i=1,2. It follows from Ei(x,a,t)=Vi(x,a,t−a) that
Ei(x,a,t)=∫ΩΓi(x,y,t,t−a)βi(y,t−a)S(y,t−a)Ii(y,t−a)S(y,t−a)+I1(y,t−a)+I2(y,t−a)+R(y,t−a)dy. | (2.5) |
Substituting (2.5) into (2.3), and dropping the Li equations from (2.3) (since they are decoupled from the other equations), we obtain the following system:
{∂S(x,t)∂t=DSΔS(x,t)+μ(x,t)−d(x,t)S(x,t)+α(x,t)R(x,t)−β1(x,t)S(x,t)I1(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t)−β2(x,t)S(x,t)I2(x,t)S(x,t)+I1(x,t)+I2(x,t)+R(x,t),∂Ii(x,t)∂t=DiΔIi(x,t)−(δi(x,t)+ri(x,t)+d(x,t))Ii(x,t)+∫τi0fi(a)⋅∫ΩΓi(x,y,t,t−a)βi(y,t−a)S(y,t−a)Ii(y,t−a)S(y,t−a)+I1(y,t−a)+I2(y,t−a)+R(y,t−a)dyda,∂R(x,t)∂t=DRΔR(x,t)+r1(x,t)I1(x,t)+r2(x,t)I2(x,t)−d(x,t)R(x,t)−α(x,t)R(x,t), i=1,2. | (2.6) |
Set τ=max{τ1,τ2}>0. Let X:=C(ˉΩ,R4) be the Banach space with a supremum norm ‖⋅‖X. Let Cτ:=C([−τ,0],X) be a Banach space with the norm ‖ϕ‖=maxθ∈[−τ,0]‖ϕ(θ)‖X, ∀ϕ∈Cτ. Define X+:=C(ˉΩ,R4+), C+τ:=C([−τ,0],X+), the (X,X+) and (Cτ,C+τ) are strongly ordered spaces. For σ>0 and a given function u(t):[−τ,σ]→X, we denote ut∈Cτ by
ut(θ)=u(t+θ), ∀θ∈[−τ,0]. |
Similarly, define Y=C(ˉΩ,R) and Y+=C(ˉΩ,R+). Furthermore, we consider the following system:
{∂ω(x,t)∂t=DSΔω(x,t)−d(x,t)ω(x,t), x∈Ω, t>0,∂ω(x,t)∂t=0, x∈∂Ω, t>0,ω(x,0)=ϕS(x), x∈Ω, ϕS∈Y+. | (2.7) |
By the arguments in [15], Eq (2.7) exists an evolution operator VS(t,s):Y+⟶Y+ for 0≤s≤t, which satisfies VS(t,t)=I, VS(t,s)VS(s,ρ)=VS(t,ρ), 0≤ρ≤s≤t, VS(t,0)ϕS=ω(x,t;ϕS), x∈Ω, t≥0, ϕS∈Y+, where ω(x,t;ϕS) is the solution of (2.7).
Consider the following periodic system:
{∂ˉωi(x,t)∂t=DiΔˉωi(x,t)−hi(x,t)ˉωi(x,t)),x∈Ω, t>0,∂ˉωi(x,t)∂n=0,x∈∂Ω, t>0,ˉωi(x,0)=ϕi(x),x∈Ω, ϕi∈Y+. | (2.8) |
and
{∂˜ωR(x,t)∂t=DRΔ˜ωR(x,t)−k(x,t)˜ωR(x,t)),x∈Ω, t>0,∂˜ωR(x,t)∂t=0,x∈∂Ω, t>0,˜ωR(x,0)=ϕR(x),x∈Ω, ϕR∈Y+, | (2.9) |
where k(x,t)=α(x,t)+d(x,t). Let Vi(t,s), i=1,2, and VR(t,s) be the evolution operators determined by (2.8) and (2.9), respectively. The periodicity hypothesis (H) combining with [9,Lemma 6.1] yield that VS(t+T,s+T)=VS(t,s), Vi(t+T,s+T)=Vi(t,s) and VR(t+T,s+T)=VR(t,s), t≥s≥0. In addition, for any t,s∈R and s<t. VS(t,s), Vi(t,s) and VR(t,s) are compact, analytic and strongly positive operators on Y+. It then follows from [9,Theorem 6.6] that there exist constants Q≥1, Qi≥1 and c0,ci∈R(i=1,2) such that
‖VS(t,s)‖,‖VR(t,s)‖≤Qe−c0(t−s), ‖Vi(t,s)‖≤Qie−ci(t−s), ∀t≥s, i=1,2. |
Let c∗i:=ˉω(Vi), where
ˉω(Vi)=inf{ω|∃M≥1: ∀s∈R, t≥0,||Vi(t+s,s)||≤M⋅eωt} |
is the exponent growth bound of the evolution operator Vi(t,s). It is clear that c∗i<0.
Define functions FS,Fi,FR:[0,∞)⟶Y respectively by
FS(t,ϕ)=μ(⋅,t)+α(⋅,t)ϕS(⋅,0)−2∑i=1βi(⋅,0)ϕS(⋅,0)ϕi(⋅,0)ϕS(⋅,0)+ϕ1(⋅,0)+ϕ2(⋅,0)+ϕR(⋅,0),Fi(t,ϕ)=∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)ϕS(y,−a)ϕi(y,−a)ϕS(y,−a)+ϕ1(y,−a)+ϕ2(y,−a)+ϕR(y,−a)dyda,FR(t,ϕ)=r1(⋅,0)ϕ1(⋅,0)+r2(⋅,0)ϕ2(⋅,0). |
Let F=(FS,F1,F2,FR), it is clear that F is a function from [0,∞) to X. Define
U(t,s):=(VS(t,s)0000V1(t,s)0000V2(t,s)0000VR(t,s)). |
Then U(t,s) is an evolution operator from X to X. Note that VS, Vi(i=1,2) and VR are analytic operators, it follows that U(t,s) is an analytic operator for (t,s)∈R2 with t≥s≥0. Let
D(AS(t))={ψ∈C2(ˉΩ)∣上∂∂nψ=0 on ∂Ω};[AS(t)ψ](x)=DSΔψ(x)−d(x,t)ψ(x), ∀ψ∈D(AS(t));D(Ai(t))={ψ∈C2(ˉΩ)∣上∂∂nψ=0 on ∂Ω};[Ai(t)ψ](x)=DiΔψ(x)−hi(x,t)ψ(x), ∀ψ∈D(Ai(t)), |
and
D(AR(t))={ψ∈C2(ˉΩ)∣上∂∂nψ=0 on ∂Ω};[AR(t)ψ](x)=DRΔψ(x)−k(x,t)ψ(x), ∀ψ∈D(AR(t)). |
Moreover, we let
A(t):=(AS(t)0000A1(t)0000A2(t)0000AR(t)). |
Then (2.3) can be rewritten as the following Cauchy problem:
{∂u(x,t)∂t=A(t)u(x,t)+F(t,ut), x∈Ω, t>0,u(x,ζ)=ϕ(x,ζ), x∈Ω, ζ∈[−τ,0], | (2.10) |
where u(x,t)=(S(x,t),I1(x,t),I2(x,t),R(x,t))T. Furthermore, it can be rewritten as the following integral equation
u(t,ϕ)=U(t,0)ϕ(0)+∫t0U(t,s)F(t,us)ds, t≥0, ϕ∈C+τ. |
Then the solution of above integral equation is called a mild solution of (2.10).
Theorem 2.1. For each ϕ∈C+τ, system (2.6) admits a unique solution u(t,ϕ) on [0,+∞) with u0=ϕ, and u(t,ϕ) is globally bounded.
Proof. By the definition of F(t,ϕ) and the assumption (H), F(t,ϕ) is locally Lipschitz continuous on R+×C+τ. We first show
limθ→0+dist(ϕ(0)+θF(t,ϕ),X+)=0, ∀(t,ϕ)∈R+×C+τ. | (2.11) |
Set
ˉβ=max{maxx∈ˉΩ,t∈[0,τ]β1(x,t),maxx∈ˉΩ,t∈[0,τ]β2(x,t)};mi(x,t)=βi(x,t)ϕS(x,0)ϕi(x,0)ϕS(x,0)+ϕ1(x,0)+ϕ2(x,0)+ϕR(x,0);ni(x,t)=βi(x,t)ϕS(x,t)ϕi(x,t)ϕS(x,t)+ϕ1(x,t)+ϕ2(x,t)+ϕR(x,t). |
For any t≥0, θ≥0 and x∈ˉΩ, ϕ∈C+τ, we have
ϕ(x,0)+θF(t,ϕ)(x)=(ϕS(x,0)+θ[μ(x,t)+α(x,t)ϕR(x,0)−2∑i=1mi(x,t)]ϕ1(x,0)+θ∫τ10f1(a)∫ΩΓ1(x,y,t,t−a)ϕ1(y,t−a)dydaϕ2(x,0)+θ∫τ20f1(a)∫ΩΓ2(x,y,t,t−a)ϕ2(y,t−a)dydaϕR(x,0)+r1(x,t)ϕ1(x,0)+r2(x,t)ϕ2(x,0))≥(ϕS(x,0)(1−θ2∑i=1βi(x,t)ϕi(x,0)ϕS(x,0)+ϕ1(x,0)+ϕ2(x,0)+ϕR(x,0))ϕ1(x,0)ϕ2(x,0)ϕR(x,0))≥(ϕS(x,0)(1−θˉβ2∑i=1ϕi(x,0)ϕS(x,0)+ϕ1(x,0)+ϕ2(x,0)+ϕR(x,0))ϕ1(x,0)ϕ2(x,0)ϕR(x,0)). |
The above inequality implies that (2.11) holds when θ is small enough. Consequently, by [25,Corollary 4] with K=X+ and S(t,s)=U(t,s), system (2.6) admits a unique mild solution u(x,t;ϕ) with u0(⋅,⋅;ϕ)=ϕ, t∈[0,tϕ]. Since U(t,s) is an analytic operator on X for any t,s∈R, s<t, it follows that u(x,t;ϕ) is a classical solution for t>τ. Set
P(t)=∫Ω(S(x,t)+2∑i=1(Li(x,t)+Ii(x,t))+R(x,t))dx, |
μmax=sup(x,t)∈ˉΩ×[0,T]μ(x,t), ˉμmax=μmax⋅|Ω|, dmin=inf(x,t)∈ˉΩ×[0,T]d(x,t). |
Then
dP(t)dt=∫Ωμ(x,t)−d(x,t)(S(x,t)+2∑i=1(Li(x,t)+Ii(x,t))+R(x,t)) −2∑i=1δi(x,t)(Li(x,t)+Ii(x,t))−2∑i=1ri(x,t)Li(x,t)dx≤∫Ωμ(x,t)dx−∫Ωd(x,t)(S(x,t)+2∑i=1(Li(x,t)+Ii(x,t))+R(x,t))dx≤ˉμmax−dminP(t), t>0. |
We obtain that there are l:=lϕ large enough and M=ˉμmaxdmin+1>0, so that for each ϕ∈C+τ, one has
P(t)≤M, ∀t≥lT+τ. |
Then ∫ΩIi(x,t)dx≤M, ∀t≥lT+τ. According to [11] and assumption (H), we obtain that Γi(x,y,t,t−a) and βi(x,t) are uniformly bounded functions for any x,y∈Ω, t∈[a,a+T]. Set Bi=supx,y∈Ω,t∈[a,a+T]Γi(x,y,t,t−a)βi(y,t−a), then we obtain
∂Ii∂t≤DiΔIi−hi(x,t)Ii(x,t)+∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)Ii(y,t−a)dyda≤DiΔIi−hi(x,t)Ii(x,t)+Bi∫τi0fi(a)∫ΩIi(y,t−a)dyda≤DiΔIi−hi(x,t)Ii(x,t)+BiMFi(τi)=DiΔIi−hi(x,t)Ii(x,t)+BiM, x∈Ω, t≥lT+τ. | (2.12) |
Consider the following equation:
{∂ωi(x,t)∂t=DiΔωi(x,t)−hi(x,t)ωi(x,t)+BiM,x∈Ω, t>lT+τ,∂ωi(x,t)∂n=0,x∈∂Ω, t>lT+τ. | (2.13) |
It is evident that system (2.13) admits a strictly positive periodic solution with the period T>0, which is globally attractive. According to (2.12), the first equation of system (2.6) can be dominated by (2.13) for any t>lT+τ. So there exists B1>0 such that for each ϕ∈C+τ, we can find a li=li(ϕ)≫l(ϕ) satisfying Ii(x,t;ϕ)≤B1(i=1,2) for x∈ˉΩ and t≥liT+τ. Thus
{∂R(x,t)∂t≤DRΔR(x,t)−k(x,t)R(x,t)+B1(r1(x,t)+r2(x,t)),x∈Ω, t>liT+τ,∂R(x,t)∂n=0,x∈∂Ω, t>liT+τ. | (2.14) |
Similarly, there exists B2>0 such that for each ϕ∈C+τ, there exists lR=lR(ϕ)≫li satisfying R(x,t;ϕ)≤B2 for x∈ˉΩ and t≥lRT+τ. Then we have
{∂S(x,t)∂t≤DSΔS(x,t)+μ(x,t)−d(x,t)S(x,t)+B2α(x,t),x∈Ω, t>lRT+τ,∂S(x,t)∂n=0,x∈∂Ω, t>lRT+τ. | (2.15) |
Hence, there are B3>0 and lS=lS(ϕ)≫lR such that for each ϕ∈C+τ, S(x,t;ϕ)≤B3(i=1,2) for x∈ˉΩ and t≥lST+τ, and hence, tϕ=+∞.
Theorem 2.2. System (2.6) generates a T-periodic semi-flow Φt:=ut(⋅):C+τ→C+τ, namely Φt(ϕ)(x,s)=ut(ϕ)(x,s)=u(x,t+s;ϕ) for any ϕ∈C+τ, t≥0 and s∈[−τ,0]. In addition, ΦT admits a global compact attractor on C+τ, where u(x,t;ϕ) is a solution of system (2.6).
Proof. By a similar argument as the proof of [26,Theorem 8.5.2], one can show that Φt(ϕ) is continuous for any ϕ∈C+τ and t≥0. In addition, similarly as the proof of [36,Lemma 2.1], we can further verify that Φt is a T-periodic semi-flow on C+τ. According to Theorem 2.1, we obtain that Φt is dissipative. Moreover, by the arguments similar to those in the proof of [15,Proposition 21.2], we get that there exists n0≥1 such that Φn0T=un0T is compact on C+τ for n0T≥τ. Following from [23,Theorem 2.9], we have that ΦT:C+τ→C+τ admits a global compact attractor.
In this section, we first analyze the threshold dynamics of a single-strain model with the help of the basic reproduction number, and then study the threshold dynamics of model (2.6).
Let Ij(x,t)≡0,∀x∈Ω, t>0, j=1,2, and i≠j. Then system (2.6) reduces to the following single-strain model:
{∂S∂t=DSΔS+μ(x,t)−d(x,t)S+α(x,t)R(x,t)−βi(x,t)S(x,t)Ii(x,t)S(x,t)+Ii(x,t)+R(x,t),∂Ii∂t=DiΔIi(x,t)−hi(x,t)Ii(x,t)+∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)S(y,t−a)Ii(y,t−a)S(y,t−a)+Ii(y,t−a)+R(y,t−a)dyda,∂R∂t=DRΔR(x,t)+ri(x,t)Ii(x,t)−d(x,t)R(x,t)−α(x,t)R(x,t). | (3.1) |
Consider the following linear equation:
{∂S(x,t)∂t=DSΔS(x,t)+μ(x,t)−d(x,t)S(x,t),x∈Ω, t>0,∂S(x,t)∂n=0,x∈∂Ω, t>0. | (3.2) |
According to [36,Lemma 2.1], there is an unique T-periodic solution S∗(x,t) of (3.2). Linearizing the Ii-equation of system (3.1) at the disease-free periodic solution (S∗,0,0), we have
{∂ωi(x,t)∂t=DiΔωi(x,t)−hi(x,t)ωi(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)ωi(y,t−a)dyda, x∈Ω, t>0,∂ωi(x,t)∂n=0, x∈∂Ω, t>0. | (3.3) |
Let
CT(ˉΩ×R,R):={u|u∈C(ˉΩ×R,R),u(x,t+T)=u(x,t),(x,t)∈Ω×R,T>0}, |
with the supremum norm, and define C+T as the positive cone of CT(ˉΩ×R,R), namely,
C+T:={u∈CT: u(t)(x)≥0, ∀t∈R, x∈ˉΩ}. |
Let ψi(x,t)∈CT(ˉΩ×R,R) be the initial distribution of infected individuals of the i-strain at the spatial position x∈ˉΩ and time t∈R, then Vi(t−a,s)ψi(s)(s<t−a) is the density of those infective individuals at location x who were infective at time s and retain infective at time t−a when time evolved from s to t−a. Furthermore, ∫t−a−∞Vi(t−a,s)ψi(s)ds is the density distribution of the accumulative infective individuals at positive x and time t−a for all previous time s<t−a. Hence the density of new infected individuals at time t and location x can be written as
∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)∫t−a−∞(Vi(t−a,s)ψi(s))(x)dsdyda=∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)∫+∞a(Vi(t−a,t−s)ψi(t−s))(x)dsdyda. |
Defining operator Ci:CT(ˉΩ×R,R)⟶CT(ˉΩ×R,R) by
(Ciψi)(x,t)=∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)ψi(y,t−a)dyda. |
Set
Ai(ψi)(x,t)=(Ciψi)(x,t), Bi(ψi)(x,t)=∫+∞a(Vi(t,t−s+a)ψi(t−s+a))(x)ds. |
Defining other operators Li,ˆLi:CT⟶CT by
(Liψi):=∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)∫+∞aVi(t−a,t−s)ψi(t−s)(x)dsdyda,(ˆLiψi)(x,t):=∫+∞0Vi(t,t−s)(Ciψi)(t−s)(x)ds, t∈R, s≥0. |
Clearly, Li=AiBi, ˆLi=BiAi, Li and ˆLi are compact, bounded and positive operators. Let r(Li) and r(ˆLi) are the spectral radius of Li and ˆLi respectively, then r(Li)=r(ˆLi). Similar to [18,20], we define the basic reproduction number for system (3.1), that is, Ri0=r(Li)=r(ˆLi).
Define Q:=C([−τ,0],Y), and let ||ϕ||Q:=maxθ∈[−τ,0]||ϕ(θ)||Y for any ϕ∈Q. Denote Q+:=C([−τ,0],Y+) as the positive cone of Q. Then (Q,Q+) is strongly ordered Banach space. Let P:=C(ˉΩ,R3) be the Banach space with supremum norm ‖⋅‖P. For τ>0, let Dτ:=C([−τ,0],P) be the Banach space with ‖ϕ‖=maxθ∈[−τ,0]‖ϕ(θ)‖P for all ϕ∈Dτ. Define P+:=C(ˉΩ,R3+) and D+τ:=C([−τ,0],P+), then both (P,P+) and (Dτ,D+τ) are strongly ordered space. By the arguments in [21,39], we have the following observation:
Theorem 3.1. The signs of Ri0−1 and ri−1 are same.
Consider the following equation
{∂ωi(x,t)∂t=DiΔωi(x,t)−hi(x,t)ωi(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)B3βi(y,t−a)B3+ωi(y,t−a)ωi(y,t−a)dyda, x∈Ω, t>0,∂ωi(x,s)=ψi(x,s), ψi∈Q+, x∈Ω, s∈[−τi,0],∂ωi(x,t)∂n=0, x∈∂Ω, t>0, | (3.4) |
where B3 is the constant in the proof of Theorem 2.1.
Theorem 3.2. Assume that ωi(x,t;ψi) is the solution of (3.4) with an initial value of ψi∈Q. If Ri0=1 and βi(x,t)>0 for all x∈ˉΩ, t>0, then ωi(x,t)≡0 is globally attractive.
Proof. By a straightforward computation, one has that (3.4) is dominated by (3.3). Define the map Pnoi:Q→Q by Pnoi(ψi)=ωn0i,T with ωn0i,T=ωi(x,n0T+s;ψi), where ωi(x,t;ψi) is the solution of (3.3). Similar to the argument in [18], Pnoi is strongly positive on Q+ when βi(x,t)>0,∀x∈ˉΩ, t>0. It follows from [20,Lemma 3.1] that Pnoi admits a positive and simple eigenvalue ri, and a strongly positive eigenfunction defined by ψi, that is Pi(ψi)=riψi. It follows from the strong positivity of ψi that ωi(x,t;ψi)≫0. According to Theorem 3.2, we have ri=1, and hence, μi=0. By similar arguments as the proof of [18,Lemma 3.2], we can show that there is a positive T-periodic function ν∗i(x,t)=e−μi⋅0ωi(x,t;ψi)=ωi(x,t;ψi) such that ν∗i(x,t) is a solution of (3.3). Then for each initial value ψi(x,s)∈Q, there exists a constant k>0 such that ψi(x,s)≤kν∗i(x,s) for all x∈Ω, t>0. Moreover, by the comparison principle, one has ωi(x,t;ψi)≤kν∗i(x,t) for all x∈Ω, t>0. Let
[0,kν∗i]Q={u∈Q:0≤u(x,s)≤kν∗i(x,s), ∀x∈ˉΩ, s∈[−τi,0]}, |
then
Sn0i(ψi):=ωi(x,noTω+S;ψI)⊆[0,kν∗i]Q, ∀x∈ˉΩ, s∈[−τi,0]. |
Hence the positive orbit γ+(ψi):={Skn0i(ψi):∀k∈N} of Sn0i(⋅) is precompact, and Sn0i maps [0,kν∗i]Q into [0,kν∗i]Q, Due to comparison principle, we get Sn0i(⋅) is monotone. According to [40,Theorem 2.2.2], we obtain that ωi(x,t)≡0 is globally attractive.
Theorem 3.3. Suppose that ˉS(x,t;ψ)=(S(x,t;ψ),Ii(x,t;ψ),R(x,t;ψ)) is the solution of (3.1) with the initial data ψ. If Ii(x,t0;ψ)≢0 for some t0≥0, then Ii(x,t;ψ)>0, ∀x∈ˉΩ, t>t0.
Proof. Obviously, for the secondly equation of (3.1), we get
{∂Ii(x,t)∂t≥DiΔIi(x,t)−hi(x,t)Ii(x,t), x∈Ω, t>0,∂Ii(x,t)∂n=0, x∈∂Ω, t>0, i=1,2, |
and Ii(x,t0;ψ)≢0, t0≥0, i=1,2. It follows from [15,Proposition 13.1] that Ii(x,t;ψ)>0 for all x∈ˉΩ and t>t0.
Theorem 3.4. Suppose that ˉS(x,t;ψ)=(S(x,t;ψ),Ii(x,t;ψ),R(x,t;ψ)) be the solution of (3.1) with the initial data ψ=(ψS,ψi,ψR)∈Dτ, i=1,2. Thenone has
(1) If Ri0=1 and βi(x,t)>0 for all x∈Ω and t>0, then (S∗,0,0) is globally attractive;
(2) If Ri0<1, then (S∗,0,0) is globally attractive;
(3) If Ri0>1, then there is a M>0 such that for any ψ∈D+τ, one has
lim inft→∞S(x,t;ψ)>M, lim inft→∞Ii(x,t;ψ)>M, lim inft→∞R(x,t;ψ)>M |
uniformly for x∈ˉΩ.
Proof. (1) According to the proof of Theorem 2.1, for t>lsT+τ, we have S(x,t;ϕ)≤B3, ∀x∈ˉΩ, ϕ∈C+τ. Thus, when t>lsT+τ, the second equation of (3.1) is dominated by (3.4) for x∈ˉΩ. In addition, one has Ii(x,t;ψ)≤ωi(x,t) for x∈ˉΩ and t>lsT+τ. Since Ri0=1 and βi(x,t)>0 for x∈ˉΩ, t>0. It follows from Theorem 3.5 that limt→∞ωi(x,t)=0 for all x∈ˉΩ. In addition, one has limt→∞Ii(x,t;ψ)=0 for all x∈ˉΩ, and limt→∞R(x,t;ψ)=0 for all x∈ˉΩ. Hence the first equation of (3.1) is asymptotic to (3.2). It follows from [36,Lemma 2.1] that system (3.2) admits an unique positive T-periodic solution S∗(x,t), which is globally attractive.
Let P=ΦT, J=ˉω(ψ) denotes the omega limit set for P. That is
J={(ϕ∗S,ϕ∗i,ϕ∗R)∈C+τ:∃{ki}→∞ s.t. limi→∞Pki(ϕS,ϕi,ϕR)=(ϕ∗S,ϕ∗i,ϕ∗R)}. |
It follows fron [17,Lemma 2.1] that J is an internally chain transitive sets for P. Since limt→∞Ii(x,t;ψ)=0 and limt→∞R(x,t;ψ)=0 for all x∈ˉΩ, then J=J1×{ˆ0}×{ˆ0}. According to Theorem 3.5, one has ˆ0∉J1. Let ω(x,t;ψS(⋅,0)) be the solution of (3.2) with the initial value ω(x,0)=ψS(x,0), where ψS∈Q+. Define
ωt(x,θ;ψS)={ω(x,θ+t;ψS(0)) t+θ>0, t>0, θ∈[−τ,0],ψ(x,θ+t) t+θ≤0, t>0, θ∈[−τ,0]. |
Then we define the solution semiflow ωt for (3.2).
Let ˉP=ωT(ψS), ˉω(ψS) denotes the omega limit set of ˉP. According to [36,Lemma 2.1], one has ˉω(ψS)={S∗}. Since P(J)=J and Ii(x,t;(ψS,ˆ0,ˆ0))≡0, R(x,t;(ψS,ˆ0,ˆ0))≡0, P(J)=ˉP(J1)×{ˆ0}×{ˆ0}, then ˉP(J1)=J1. Therefore, J1 is an internally chain transitive sets for ˉP. It follows from [36,Lemma 2.1] that {S∗} is globally attractive on Q+. In addition, J1∩WS{S∗}=J1∩ Q+=∅, where WS{S∗} is the stable set of S∗. According to [40,Theorem 1.2.1], one has J1⊆{S∗}, then J1={S∗}. Consequently, J={(S∗,0,0)}. By the definition of J, we have
limt→∞∥(S(⋅,t;ψ),Ii(⋅,t;ψ),R(⋅,t;ψ))−(S∗(⋅,t),0,0)∥=0. |
(2) Consider equation
{∂ω∗i(x,t)∂t=DiΔω∗i(x,t)−hi(x,t)ω∗i(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)(βi(y,t−a)+ε)ω∗i(y,t−a)dyda, x∈Ω, t>0,∂ω∗i(x,t)∂n=0, x∈∂Ω, t>0. | (3.5) |
Since Ri0<1, it follows from Theorem 2.1 that ri<1. Thus there exists a constant ε0>0 such that ri,ε<1 for ε∈[0,ε0). Then μi,ε:=lnri,εT<0 for ε∈[0,ε0). Similar to the proof of [18,Lemma 3.2], there is positive T-periodic function νεi(x,t) such that ωεi(x,t)=eμi,ενεi(x,t) satisfies (3.5). Since μi,ε<0, limt→∞ωεi(x,t)=0 uniformly for x∈Ω.
For x∈Ω, t>0, one has
{∂Ii(x,t)∂t≤DiΔIi(x,t)−hi(x,t)Ii(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)(βi(y,t−a)+ε)Ii(y,t−a)dyda, x∈Ω, t>0,∂Ii(x,t)∂n=0, x∈∂Ω, t>0. | (3.6) |
For any given initial distribution ψ∈D+τ, due to the boundedness of Ii(x,t;ψ), there exists α>0 such that Ii(x,t;ψ)≤α⋅ωεi(x,t), ∀t∈[kT,kT+τ], x∈ˉΩ, and hence, Ii(x,t;ψ)≤α⋅ωεi(x,t) for t≥kT+τ. Then limt→∞Ii(x,t;ψ)=0 and limt→∞R(x,t;ψ)=0 for all x∈ˉΩ. Furthermore, similar to the proof of (1), we have
limt→∞∥(S(⋅,t;ψ),Ii(⋅,t;ψ),R(⋅,t;ψ))−(S∗(⋅,t),0,0)∥=0. |
(3) Let
Wi0={ψ=(ψS,ψi,ψR)∈D+τ:ψi(⋅,0)≠0}, |
∂Wi0:=D+τ∖Wi0={ψ=(ψS,ψi,ψR)∈D+τ:ψi(⋅,0)≡0}. |
Define Φt:D+τ→D+τ by Φt(ψ)(x,s)=(S(x,t+s;ψ),Ii(x,t+s;ψ),R(x,t+s;ψ)). By Theorem 3.6, we know that Ii(x,t+s;ψ)>0 for any ψ∈W0i, x∈ˉΩ and t>0. Thus there exists k∈N such that Φkn0T(Wi0)⊆Wi0. Define
Mi∂:={ψ∈∂Wi0:Φkn0T(ψ)∈∂Wi0, ∀k∈N}. |
Let M:=(S∗,0,0) and ω(ψ) be the omega limit set of the orbit γ+:={Φkn0T(ψ):∀k∈N}. For any given ψ∈Mi∂, we have Φkn0T(ψ)∈∂Wi0. Thus Ii(x,t;ψ)≡0, ∀x∈ˉΩ, t≥0. Therefore R(x,t;ψ)≡0 for any x∈ˉΩ and t≥0. By similar arguments as the proof of (1), we have
limt→∞∥(S(⋅,t;ψ),Ii(⋅,t;ψ),R(⋅,t;ψ))−(S∗(⋅,t),0,0)∥=0. |
That is ω(ψ)=M for any ψ∈Mi∂.
For sufficient small ˉθ>0, consider the following system:
{∂vθi(x,t)∂t=DiΔvθi(x,t)−hi(x,t)vθi(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)(S∗(y,t−a)−ˉθ)S∗(y,t−a)+ˉθvθi(y,t−a)dyda, x∈Ω, t>0,∂vθi(x,s)=ψi(x,s), ψi∈Q+, x∈Ω, s∈[−τi,0],∂vθi(x,t)∂n=0, x∈∂Ω, t>0. | (3.7) |
Let vθi(x,t;ψi) be the solution of (3.7). Note vθi,n0T(ψi)(x,s)=vθi(x,s+n0T;ψi) for all x∈Ω and s∈[−τi,0]. Define the poincarˊe map (χiθ)n0:Q+→Q+ by (χiθ)n0(ψi)=vθi,n0T(ψi). It is easy to prove that (χiθ)n0 is a compact, strongly positive operator. Let (riθ)n0 be the spectral radius of (χiθ)n0. According to [15,Theorem 7.1], there is a positive eigenvalue (riθ)n0 and a positive eigenfunction ˜φi such that (χiθ)n0=(riθ)n0˜φi. Since Ri0>1, it follows from Theorem 2.1 that ri>1. Then there exists a sufficient small number θ1>0 such that riθ>1 for θ∈(0,θ1).
By the continuous dependence of solutions on initial value, there exists θ0∈(0,θ1) such that
‖S(x,t;ϕ),Ii(x,t;ϕ),R(x,t;ϕ)−(S∗(x,t),0,0)‖<ˉθ, ∀x∈ˉΩ, t∈[0,T], |
if
‖(ϕS(x,s),ϕi(x,s),ϕR(x,s))−(S∗(x,s),0,0)‖<θ0, x∈ˉΩ, s∈[−τi,0]. |
Claim. M is a uniformly weak repeller for Wi0, that is,
lim supk→∞‖Φkn0T(ψ)−M‖≥θ0, ∀ψ∈Wi0. |
Suppose, by contradiction, there exists ψ0∈Wi0 such that
lim supk→∞‖Φkn0T(ψ)−M‖<θ0. |
Then there exist a k0∈N such that
|S(x,kn0T+s;ψ0)−S∗|<θ0, |Ii(x,kn0T+s;ψ0|<θ0,|R(x,kn0T+s;ψ0|<θ0, ∀x∈ˉΩ, s∈[−τi,0], k≥k0. |
According to (3.11), for any t>kn0T and x∈ˉΩ,
S∗−ˉθ<S(x,t;ψ0)<S∗+ˉθ, 0<Ii(x,t;ψ0)<ˉθ, 0<R(x,t;ψ0)<ˉθ. |
Therefore, for Ii-equation of (3.1), we have
∂Ii(x,t)∂t≥DiΔIi(x,t)−hi(x,t)Ii(x,t) +∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)(S∗(y,t−a)−ˉθ)S∗(y,t−a)+ˉθIi(y,t−a)dyda, x∈Ω,t>(k0+1)n0T. | (3.8) |
Since
Ii(x,t;ψ0)>0, x∈ˉΩ, t>(k0+1)n0T, |
there exist some κ>0, such that
Ii(x,(k0+1)n0T+s;ψ0)≥κ˜φi(x,s), ∀x∈ˉΩ, s∈[−τi,0]. |
By (3.12) and the comparison principle, we have
Ii(x,t+s;ψ0)≥κνθi(x,t−(k0+1)n0T+s;˜φi), ∀x∈ˉΩ, t>(k0+1)n0T. |
Therefore, we have
Ii(x,kn0T+s;ψ0)≥κνθi(x,k−(k0+1)n0T+s;˜φi)=κ(riθ)(k−k0−1)n0˜φi(x,s), | (3.9) |
where k≥k0+1, s∈[−τi,0]. Since ˜φi(x,s)>0 for (x,s)∈ˉΩ×[−τi,0], there is (xi,si)∈ˉΩ×[−τi,0] such that ˆφi(xi,si)>0. It follows from (riθ)n0>1 that Ii(xi,kn0T+si;ψ0)→+∞ as k→∞, which contradicts to Ii(x,t;ψ0)∈(0,ˉθ).
Let WS(M) be the stable set of M. In conclusion, WS(M)=Mi∂; M is an isolated invariant set for Φn0T in Wi0; WS(M)∩Wi0=Mi∂∩Wi0=∅. According to [40,Theorem 1.3.1] and [40,Remark 1.3.1], one has there is ˉσ>o such that infd(ω(ψ),∂Wi0)≥ˉσ for any ψ∈Wi0. That is lim inft→∞d(Φkn0T,∂Wi0)≥ˉσ for any ψ∈Wi0. Therefore, Φn0T:D+τ→D+τ is uniformly persistent with respect to (Wi0,∂Wi0). Similar to Theorem 2.1, it can be proved that the solution ˉS(x,t;ψ) of 3.1 is globally bounded for any ψ∈D+τ. Therefore, Φn0T:D+τ→D+τ is point dissipative. It is easy to prove that Φn0T is compact on Wi0 for n0T>τi. It follows from [40,Section 1.1] that the compact map Φn0T is an α−contraction of order 0, and an α−contraction of order 0 is α−condensing. Then according to [23,Theorem 4.5], Φn0T:Wi0→Wi0 admits a compact global attractor Zi0.
Similar to the proof of [22,Theroem 4.1], let P:D+τ→[0,+∞) by
P(ψ)=minx∈ˉΩψi(x,0), ∀ψ∈D+τ. |
Since Φn0T(Zi0)=Zi0, we have that ψi(⋅,0)>0 for any ψ∈Zi0. Let Bi:=∪t∈[0,n0T]Φt(Zi0), then Bi⊆Wi0. In addition, we get limt→∞d(Φt(ψ),Bi)=0 for all ψ∈Wi0. Since Bi is a compact subset of Wi0, we have minψ∈BiP(ψ)>0. Thus, there exists a σ∗>0 such that lim inft→∞Ii(⋅,t;ψ)≥σ∗. Furthermore, according to Theorem 3.6, there exists M>0 such that lim inft→∞Ii(⋅,t;ψ)≥M.
Consider the following equation:
{∂ˉS(x,t)∂t=DˉSΔˉS(x,t)+μ(x,t)−d(x,t)ˉS(x,t)−β1(x,t)ˉS(x,t)−β2(x,t)ˉS(x,t), x∈Ω, t>0,∂ˉS(x,t)∂n=0, x∈∂Ω, t>0, i=1,2. | (3.10) |
According to [36,Lemma 2.1], equation (3.10) admits a unique positive solution ˉS∗, which is T-periodic with respect to t∈R. Obviously, for the S-equation of (2.6), we have
{∂S(x,t)∂t≥DSΔS(x,t)+μ(x,t)−d(x,t)S(x,t)−β1(x,t)S(x,t),−β2(x,t)S(x,t), x∈Ω, t>0,∂S(x,t)∂n=0, x∈∂Ω, t>0, i=1,2. | (3.11) |
It follows from the comparison principle, one has
lim inft→∞S(x,t)≥ˉS∗(x,t), ∀x∈ˉΩ. |
According to Theorem 2.1, there exist constants B1,B2 and lR, such that
Ii(x,t;ϕ)≤B1(i=1,2), R(x,t;ϕ)≤B2 |
for t≥lRT+τ. Consider the following equation:
{∂ui(x,t)∂t=DiΔui(x,t)−hi(x,t)ui(x,t)+∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)ˉS∗(x,t)ˉS∗(x,t)+B1+B2ui(y,t−a)dyda, x∈Ω, t>0,∂ui(x,t)∂n=0, x∈∂Ω, t>0, i=1,2. | (3.12) |
Let ui(x,t;ϕi) be the solution of (3.12) for ϕi∈Q,(x,s)∈ˉΩ×[−τ,0]. Define ˉPi:Q→Q by ˉPi(ϕi)=ui,T(ϕi) for any ϕi∈Q, where ui,T(ϕi)(x,t)=ui(x,s+T;ϕi), (x,s)∈ˉΩ×[−τ,0]. Let ρ0i be the spectral of ˉPi. We define the linear operator ˉLi:CT→CT by:
ˉLi(ψi)(x,t)=∫τi0fi(a)∫ΩΓi(x,y,t,t−a)βi(y,t−a)S∗(x,t)S∗(x,t)+B1+B2⋅∫∞a(Vi(t−a,t−s)ψi(t−s))(y)dsdyda. |
Then the operator ˉLi is positive and bounded on CT(ˉΩ×R,R). Let r(ˉLi) denote the spectral radius of ˉLi. Similar to [18,20], define the invasion number ˆRi0 for strain i by ˆRi0:=r(ˉLi), and we have the following result.
Theorem 3.5. The signs of ˆRi0−1 and ρ0i−1 are same.
By the arguments similar to those in the proof of [38,Proposition 5.10], we further have the following observation.
Theorem 3.6. If ˆRi0>1, then Ri0>1, i=1,2.
Theorem 3.7. Suppose that ˆRi0>1(i=1,2). Then for any ψ=(ψS,ψ1,ψ2,ψR)∈C+τ, ψi≢0(i=1,2), there is an η>0 such that
lim inft→∞S(x,t;ψ)≥η, lim inft→∞Ii(x,t;ψ)≥η, i=1,2. |
Proof. According to Theorem 3.6 and ˆRi0>1(i=1,2), one has Ri0>1(i=1,2). Let
Z0={ψ=(ψS,ψ1,ψ2,ψR)∈C+τ:ψ1(⋅,0)≢0 且 ψ2(⋅,0)≢0}, |
∂Z0:=C+τ∖W0={ψ=(ψS,ψ1,ψ2,ψR)∈C+τ:ψ1(⋅,0)≡0 或 ψ2(⋅,0)≡0}, |
and
Z∂:={ψ∈∂Z0:Φkn0T(ψ)∈∂Z0, ∀k∈N}. |
Define Φt:C+τ→C+τ by Φt(ψ)(x,s)=˜S(x,t+s;ψ), ∀ψ∈C+τ and Φkn0T(ψ):=˜S(x,n0T+s;ψ) for k∈N and (x,s)∈ˉΩ×[−τ,0]. It is easy to obtain that Φt(Z0)∈Z0 for t>0. Let
E0:=(ˉS∗,0,0,0), E1:={(ψS,ψ1,0,ψR)}, E2:={(ψS,0,ψ2,ψR)}, |
and ˉω(ψ) denotes the omega limit set of the orbit γ+:={Φkn0T(ψ):∀k∈N} for ψ∈Z∂, we then have the following claims.
Claim 1. ∪ψ∈Z∂ˉω(ψ)=E0∪E2∪E2.
For any Φkn0T(ψ)∈Z∂, it can be see that Φkn0T(ψ)∈Z∂, ∀k∈N. Then I1(x,t;ψ)≡0 or I2(x,t;ψ)≡0 for x∈ˉΩ and t>0. Suppose, by contradiction, if there exists ti>0 such that Ii(x,t;ψ)≢0 on x∈ˉΩ, i=1,2. Then the strong positivity of Vi(t,s)(t>s) implies that Ii(x,t;ψ)>0 for all t>ti and x∈ˉΩ, i=1,2, which contradicts with the fact Φkn0T(ψ)∈Z∂. If I1(x,t;ψ)≡0 on (x,t)∈ˉΩ×R+, it follows from Theorem 3.7 that ˉω(ψ)=E0∪E2. If I2(x,t;ψ)≡0 on (x,t)∈ˉΩ×R+. Similarly, one has ˉω(ψ)=E0∪E1. Therefore, Claim 1 holds.
Claim 2. E0 is a uniformly weak repeller for Z0, in the sense that,
lim supk→∞‖Φkn0T(ψ)−E0|≥ε0, ∀ψ∈Z0 |
for ε0>0. The proof of Claim 2 is similar to those in Theorem 3.4(3), so we omit it.
Claim 3. E1 and E2 is a uniformly weak repeller for Z0, in the sense that,
lim supk→∞‖Φkn0T(ψ)−Ei|≥ε0, ∀ψ∈Z0, i=1,2 |
for some ε0>0 small enough. We only give the proof for E1, the proof of E2 is similar. Due to Theorem 2.1, there are B1,B2 and lR≫0, such that
Ii(x,t;ϕ)≤B1(i=1,2), R(x,t;ϕ)≤B2 |
for t≥lRT+τ. For sufficient small ε>0, we consider the following system:
{∂ωε2∂t=D2Δωε2(x,t)−h2(x,t)ωε2(x,t)+∫τ20f2(a)∫ΩΓ2(x,y,t,t−a)β2(y,t−a)ˉS∗(x,t)−εˉS∗(x,t)+B1+B2ωε2(y,t−a)dyda, x∈Ω, t>0,∂ωε2∂n=0, x∈∂Ω, t>0, i=1,2, | (3.13) |
where ˉS∗ is the positive periodic solution of (3.11). Let ωε2(x,t;ψ2) be the solution of (3.13) with initial data ωε2(x,s)=ψ2(x,s), ψ2∈Q+, x∈Ω, s∈[−τ,0]. Note ωε2,n0T(ψ2)(x,s)=ωε2(x,s+n0T;ψ2) for all x∈Ω and s∈[−τ1,0]. Define (Ψε2)n0:Q+→Q+ by (Ψε2)n0(ψ2)=ωε2,n0T(ψ2). Let ˆr2ε and (ˆr2ε)n0 be the spectral radius of Ψε2 and (Ψε2)n0, respectively. It is easy to prove that (Ψε2)n0 is compact, strongly positive operator. According to [15,Theorem 7.1], we get that (Ψε2)n0 admits a positive and simple eigenvalue (ˆr2ε)n0 and a positive eigenfunction φ2 satisfying (Ψε2)n0=(ˆr2ε)n0φ2. Since R20>1, it follows from Theorem 3.5 that ρ02>1, then there exists a sufficient small number ε1>0 such that r2ε>1 for any ε∈(0,ε1).
By the continuous dependence of solution on initial value, there exists ε0∈(0,ε1) such that
‖ΦkT(ψ)−E1‖<ˉε, ∀x∈ˉΩ, t∈[0,T], | (3.14) |
if
‖ϕ(x,s)−E1‖<ε0, x∈ˉΩ, s∈[−τ,0]. |
Suppose, by contradiction, there exists ψ0∈W0 such that
lim supk→∞‖Φkn0T(ψ)−E1‖<ε0. |
That is, there is k0∈N such that
ˉS∗−ˉε<S(x,t;ψ0)<ˉS∗+ˉε; 0<I1(x,t;ψ0)<B1; |
and
0<I2(x,t;ψ0)<ˉε; 0<R(x,t;ψ0)<B2 |
for all k≥k0. Therefore, for I2-equation of (2.6), we have
∂I2(x,t)∂t≥D2ΔI2(x,t)−h2(x,t)I2(x,t)+∫τ20f1(a)∫ΩΓ2(x,y,t,t−a)β2(y,t−a)ˉS∗(y,t−a)−ˉεˉS∗+B1+B2I2(y,t−a)dyda | (3.15) |
for x∈Ω and t>(k0+1)n0T. Since
I2(x,t;ψ0)>0, ∀x∈ˉΩ, t>(k0+1)n0T, |
there is some κ>0, such that
I2(x,(k0+1)n0T+s;ψ0)≥κφ2(x,s), ∀x∈ˉΩ, s∈[−τ2,0]. |
By (3.15) and the comparison principle, we have
I2(x,t+s;ψ0)≥ωε2(x,t−(k0+1)n0T+s;φ2), ∀x∈ˉΩ, t>(k0+1)n0T. |
Therefore, we have
I2(x,kn0T+s;ψ0)≥κωε2(x,k−(k0+1)n0T+s;φ2)=κ(ˆr2ε)(k−k0−1)n0φ2(x,s), | (3.16) |
where k≥k0+1, s∈[−τ2,0]. Since φ2(x,s)>0 for (x,s)∈ˉΩ×[−τ2,0], there is (x2,s2)∈ˉΩ×[−τ2,0] such that φ2(x2,s2)>0. It follows from (r2ε)n0>1 that I2(x2,kn0T+s2;ψ0)→+∞ as k→∞, which contradicts to I2(x,t;ψ0)∈(0,ˉε).
Let Θ:=E0∪E1∪E2, WS(Θ) be the stable set of Θ. In conclusion, WS(Θ)=Z∂; Θ is an isolated invariant set for Φn0T in Z0, WS(Θ)∩Z0=Z∂∩Z0=∅. According to [10,Theorem 1.3.1] and [10,Remark 1.3.1], there exists ˉσ>0 such that infd(ω(ψ),∂Z0)≥ˉσ for all ψ∈Z0. That is, lim inft→∞d(Φkn0T,∂Z0)≥ˉσ for any ψ∈Z0. Therefore, Φn0T:C+τ→C+τ is uniformly persistent with respect to (Z0,∂Z0). Similar to Theorem 2.1, it can be proved that the solution ˜S(x,t;ψ) of (2.6) is globally bounded for any ψ∈D+τ. Therefore, Φn0T:C+τ→C+τis point dissipative. It is easy to prove that Φn0T is compact on Z0 for n0T>τ1. It then follows from [40,Section 1.1] that the compact map Φn0T is an α−contraction of order 0, and an α−contraction of order 0 is α−condensing. Then according to [23,Theorem 4.5], we obtain that Φn0T:Z0→Z0 admits a compact global attractor N0.
Similar to the proof of [22,Theroem 4.1], let P:C+τ→[0,+∞) by
P(ψ)=min{minx∈ˉΩψ1(x,0),minx∈ˉΩψ2(x,0)}, ∀ψ∈C+τ. |
Since Φn0T(N0)=N0, we have ψi(⋅,0)>0 for any ψ∈N0. Let B0:=∪t∈[0,n0T]Φt(N0), then B0⊆Z0. In addition, we get limt→∞d(Φt(ψ),B0)=0 for all ψ∈Z0. Since B0 is a compact subset of Z0. We have minψ∈B0P(ψ)>0. Thus, there exists η>0 such that lim inft→∞I1(⋅,t;ψ)≥η.
In this subsection, under the condition that the invasion numbers on two strains are greater than 1, it is proved that two strains will always persist uniformly. By the arguments similar to those in the proof of Theorems 3.7 and 3.2, we have the following observations.
Theorem 3.8. Suppose that ˜S(x,t;ψ)=(S(x,t;ψ),I1(x,t;ψ),I2(x,t;ψ),R(x,t;ψ)) is the solution of (2.6) with initial data ψ=(ψS,ψ1,ψ2,ψR)∈Cτ. If R10>1>R20 and ψ1(⋅,0)≢0, then
limt→∞I2(x,t;ψ)=0, |
and there is P>0 such that
lim inft→∞I1(x,t;ψ)≥P, | (3.17) |
uniformly for x∈ˉΩ.
Theorem 3.9. Suppose that R10>1=R20 and β2(x,t)>0 on (x,t)∈ˉΩ×[0,∞). If C+τ satisfies ψ1(⋅,0)≢0, then we have
limt→∞I2(x,t;ψ)=0, |
and there is P>0 such that
lim inft→∞I1(x,t;ψ)≥P, |
uniformly for x∈ˉΩ.
Theorem 3.10. Suppose that R20>1>R10, if ψ∈C+τ satisfies ψ2(⋅,0)≢0, then we have
limt→∞I1(x,t;ψ)=0, |
and there is P>0 such that
lim inft→∞I2(x,t;ψ)≥P, | (3.18) |
uniformly for x∈ˉΩ.
Theorem 3.11. Suppose that R20>1=R10 and β1(x,t)>0 on (x,t)∈ˉΩ×[0,∞). If ψ∈C+τ satisfies ψ2(⋅,0)≢0, then we have
limt→∞I1(x,t;ψ)=0, |
and there is P>0 such that
lim inft→∞I2(x,t;ψ)≥P, |
uniformly for x∈ˉΩ.
Finally, we show that the periodic solution (S∗,0,0,0) of (2.6) is globally attractive under some conditions.
Theorem 3.12. Suppose that Ri0<1 for i=1,2. Then the periodic (S∗,0,0,0) of (2.6) is globally attractive.
Proof. Due to Ri0<1, i=1,2, similar to Theorem 3.4, one has
limt→∞Ii(x,t;ψ)=0, ∀x∈ˉΩ, ψ∈C+τ, i=1,2. |
By using the theory of chain transitive sets, we get
limt→∞S(x,t;ψ)=S∗(x,t),∀x∈ˉΩ, ψ∈C+τ. |
Therefore
limt→∞∥(S(⋅,t;ψ),I1(⋅,t;ψ),I2(⋅,t;ψ),R(⋅,t;ψ))−(S∗(⋅,t),0,0,0)∥=0. |
That is (S∗,0,0,0) is globally attractive.
Theorem 3.13. Suppose that Ri0=1 and βi(x,t)>0 on ˉΩ×[0,∞) for both i=1,2. Then the periodic (S∗,0,0,0) of (2.6) is globally attractive.
Proof. The proof is similar to Theorem 3.12 by using Theorem 3.2.
Combining Theorem 3.12 with Theorem 3.13, furthermore, we have the following conclusion.
Theorem 3.14. If Ri0<1, Rj0=1 and βj(x,t)>0 on (x,t)∈ˉΩ×[0,∞), i,j=1,2, i≠j, then the periodic (S∗,0,0,0) of (2.6) is globally attractive.
In this paper, we proposed and investigated a two-strain SIRS epidemic model with distributed delay and spatiotemporal heterogeneity. The model is well suitable for simulating the pathogen mutation which is widely founded in variety viral infectious diseases. We have to remark that when the spatiotemporal heterogeneity and distributed delay are incorporated simultaneously, the analysis for the model becomes more difficult. To overcome these difficulties, we used the theory of chain transitive sets and persistence. After introducing the basic reproduction number Ri0 and the invasion number ˆRi0 for each strain i, i=1,2, we established the threshold dynamics for single-strain model and two-strain model, respectively. For the single-strain case, the threshold dynamics results shows that the basic reproduction number Ri0 is a threshold to determine whether the strain i can be persistent. In addition, in such case, we obtained a sufficient condition for the global attraction of the disease free equilibrium when Ri0=1, i=1,2. Under the condition that two strains is incorporated, we showed that if both of the invasion numbers ˆRi0 are all larger than unit, then the two strains will be persistent uniformly. However, if only one of the reproduction numbers is larger than unit, that is, the other is less than unit, then the strain with larger reproduction number persists, while the strain with the smaller reproduction number dies out. This phenomenon is so called "competitive exclusion"[33]. Further, if both of the two reproduction numbers Ri0 are all less than unit, then the corresponding disease free equilibrium is globally attractive.
Apparently, the dynamical properties of the two-strain model are much more complicated than that of the single-strain case. The most fascinating phenomenon is the appearance of "competitive exclusion" in the two strain model. Generally speaking, the strain with highest basic reproduction number will eliminate the other strain. As is well known, in reality, proper vaccination is a critical for the prevention and control of the most viral infectious disease. Thereby, with the mutating of viruses, the main thing is to ensure the vaccine as safe and effective as possible. However, it is easy to make vaccine administration error. Although some improperly administered vaccines may be valid, sometimes such errors increases the possibility of vaccine recipients being unprotected against viral infection. This paper incorporated the distributed delay, seasonal factor effects and spatial heterogeneity into a two-strain SIRS simultaneously, so the model is more in line with reality. Further, based on these realistic factors, we obtained some valuable results for proper vaccination to viral infection theoretically.
The first author was supported by the innovation fund project for colleges and universities of Gansu Province of China (2021B-254), the second author was supported by NSF of China (12071193) and Natural Science Foundation of Gansu Province of China (21JR7RA549).
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
[1] |
Ros E (2010) Health benefits of nut consumption. Nutrients 2: 652-682. doi: 10.3390/nu2070652
![]() |
[2] | O'Neil CE, Keast DR, Fulgoni VL III, et al. (2010) Tree nut consumption improves nutrient intake and diet quality in US adults: an analysis of National Health and Nutrition Examination Survey (NHANES) 1999-2004. Asia Pac J Clin Nutr 19: 142-150. |
[3] |
O'Neil CE, Nicklas TA, Fulgoni VL III (2015) Tree nut consumption is associated with better nutrient adequacy and diet quality in adults: National Health and Nutrition Examination Survey 2005-2010. Nutrients 7: 595-607. doi: 10.3390/nu7010595
![]() |
[4] | Mukuddem-Petersen J, Oosthuizen W, Jerling JC (2005) A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 135: 2082-2089. |
[5] |
Ros E, Mataix J (2006) Fatty acid composition of nuts--implications for cardiovascular health. Br J Nutr 96: S29-S35. doi: 10.1017/BJN20061861
![]() |
[6] |
Ros E (2015) Nuts and CVD. Br J Nutr 113: S111-S120. doi: 10.1017/S0007114514003924
![]() |
[7] |
Estruch R, Ros E, Salas-Salvadó J, et al; PREDIMED Study Investigators. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368: 1279-1290. doi: 10.1056/NEJMoa1200303
![]() |
[8] |
Estruch R, Martínez-González MA, Corella D, et al; PREDIMED Study Investigators. (2016) Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol 4: 666-676. doi: 10.1016/S2213-8587(16)30085-7
![]() |
[9] |
Hernáez Á, Castañer O, Elosua R, et al. (2017) Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial. Circulation 135: 633-643. doi: 10.1161/CIRCULATIONAHA.116.023712
![]() |
[10] |
Casas R, Sacanella E, Urpí-Sardà M, et al. (2016) Long-Term Immunomodulatory Effects of a Mediterranean Diet in Adults at High Risk of Cardiovascular Disease in the PREvención con DIeta MEDiterránea (PREDIMED) Randomized Controlled Trial. J Nutr 146: 1684-1693. doi: 10.3945/jn.115.229476
![]() |
[11] |
Macaluso F, Barone R, Catanese P, et al. (2013) Do fat supplements increase physical performance? Nutrients 5: 509-524. doi: 10.3390/nu5020509
![]() |
[12] |
Jeromson S, Gallagher IJ, Galloway SD, et al. (2015) Omega-3 Fatty Acids and Skeletal Muscle Health. Mar Drugs 13: 6977-7004. doi: 10.3390/md13116977
![]() |
[13] |
Maguire LS, O'Sullivan SM, Galvin K, et al. (2004) Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 55: 171-178. doi: 10.1080/09637480410001725175
![]() |
[14] |
Ryan E, Galvin K, O'Connor TP, et al. (2006) Fatty acid profile, tocopherol, squalene and phytosterol content of brazil, pecan, pine, pistachio and cashew nuts. Int J Food Sci Nutr 57: 219-228. doi: 10.1080/09637480600768077
![]() |
[15] |
Curb JD, Wergowske G, Dobbs JC, et al. (2000) Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch Intern Med 160: 1154-1158. doi: 10.1001/archinte.160.8.1154
![]() |
[16] | O'Byrne DJ, Knauft DA, Shireman RB (1997)nLow fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles. Lipids 32: 687-695. |
[17] | Rajaram S, Burke K, Connell B, et al. (2001) A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr 131: 2275-2279. |
[18] |
Sabaté J, Fraser GE, Burke K, et al. (1993) Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med 328: 603-607. doi: 10.1056/NEJM199303043280902
![]() |
[19] | Zambón D, Sabaté J, Muñoz S, et al. (2000) Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med 132: 538-546. |
[20] |
Nieman DC, Scherr J, Luo B, et al. (2014) Influence of pistachios on performance and exercise-induced inflammation, oxidative stress, immune dysfunction, and metabolite shifts in cyclists: a randomized, crossover trial. PLoS One 9: e113725. doi: 10.1371/journal.pone.0113725
![]() |
[21] |
Flores-Mateo G, Rojas-Rueda D, Basora J, et al. (2013) Nut intake and adiposity: meta-analysis of clinical trials. Am J Clin Nutr 97: 1346-1355. doi: 10.3945/ajcn.111.031484
![]() |
[22] |
Musa-Veloso K, Paulionis L, Poon T, et al. (2016) The effects of almond consumption on fasting blood lipid levels: a systematic review and meta-analysis of randomised controlled trials. J Nutr Sci 5: e34. doi: 10.1017/jns.2016.19
![]() |
[23] |
Del Gobbo LC, Falk MC, Feldman R, et al. (2015) Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am J Clin Nutr 102: 1347-1356. doi: 10.3945/ajcn.115.110965
![]() |
[24] |
Banel DK, Hu FB (2009) Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 90: 56-63. doi: 10.3945/ajcn.2009.27457
![]() |
[25] |
Mohammadifard N, Salehi-Abargouei A, Salas-Salvadó J, et al. (2015) The effect of tree nut, peanut, and soy nut consumption on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials. Am J Clin Nutr 101: 966-982. doi: 10.3945/ajcn.114.091595
![]() |
[26] |
Mayhew AJ, de Souza RJ, Meyre D, et al. (2016) A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br J Nutr 115: 212-225. doi: 10.1017/S0007114515004316
![]() |
[27] |
Zelber-Sagi S, Salomone F, Mlynarsky L (2017) The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int 37: 936-949. doi: 10.1111/liv.13435
![]() |
[28] |
Luo T, Miranda-Garcia O, Adamson A, et al. (2016) Consumption of Walnuts in Combination with Other Whole Foods Produces Physiologic, Metabolic, and Gene Expression Changes in Obese C57BL/6J High-Fat-Fed Male Mice. J Nutr 146: 1641-1650. doi: 10.3945/jn.116.234419
![]() |
[29] | Mazokopakis EE, Liontiris MI (2017) Commentary: Health Concerns of Brazil Nut Consumption. J Altern Complement Med in press. |
[30] |
Stiefel G, Anagnostou K, Boyle RJ, et al. (2017) BSACI guideline for the diagnosis and management of peanut and tree nut allergy. Clin Exp Allergy 47: 719-739. doi: 10.1111/cea.12957
![]() |
[31] |
Tey SL, Robinson T, Gray AR, et al. (2017) Do dry roasting, lightly salting nuts affect their cardioprotective properties and acceptability? Eur J Nutr 56: 1025-1036. doi: 10.1007/s00394-015-1150-4
![]() |
[32] |
Schlörmann W, Birringer M, Böhm V, et al. (2015) Influence of roasting conditions on health-related compounds in different nuts. Food Chem 180: 77-85. doi: 10.1016/j.foodchem.2015.02.017
![]() |
[33] |
Masthoff LJ, Hoff R, Verhoeckx KC, et al. (2013) A systematic review of the effect of thermal processing on the allergenicity of tree nuts. Allergy 68: 983-993. doi: 10.1111/all.12185
![]() |
[34] |
Hamasaki H (2017) Exercise and gut microbiota: clinical implications for the feasibility of Tai Chi. J Integr Med 15: 270-281. doi: 10.1016/S2095-4964(17)60342-X
![]() |
[35] |
Yi M, Fu J, Zhou L, et al. (2014) The effect of almond consumption on elements of endurance exercise performance in trained athletes. J Int Soc Sports Nutr 11: 18. doi: 10.1186/1550-2783-11-18
![]() |
[36] |
Vedtofte MS, Jakobsen MU, Lauritzen L, et al. (2014) Association between the intake of α-linolenic acid and the risk of CHD. Br J Nutr 112: 735-743. doi: 10.1017/S000711451400138X
![]() |
[37] |
Schwingshackl L, Hoffmann G (2014) Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis 13: 154. doi: 10.1186/1476-511X-13-154
![]() |
[38] |
Cornish SM, Chilibeck PD (2009) Alpha-linolenic acid supplementation and resistance training in older adults. Appl Physiol Nutr Metab 34: 49-59. doi: 10.1139/H08-136
![]() |
[39] |
Poulsen RC, Kruger MC (2006) Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 75: 419-427. doi: 10.1016/j.plefa.2006.08.003
![]() |
[40] |
Børsheim E, Kien CL, Pearl WM (2006) Differential effects of dietary intake of palmitic acid and oleic acid on oxygen consumption during and after exercise. Metabolism 55: 1215-1221. doi: 10.1016/j.metabol.2006.05.005
![]() |
[41] |
Henique C, Mansouri A, Fumey G, et al. (2010) Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J Biol Chem 285: 36818-3627. doi: 10.1074/jbc.M110.170431
![]() |
[42] |
Mente A, de Koning L, Shannon HS, et al. (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169: 659-669. doi: 10.1001/archinternmed.2009.38
![]() |
[43] |
Myles IA (2014) Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr J 13: 61. doi: 10.1186/1475-2891-13-61
![]() |
[44] |
Francis H, Stevenson R (2013) The longer-term impacts of Western diet on human cognition and the brain. Appetite 63: 119-128. doi: 10.1016/j.appet.2012.12.018
![]() |
[45] |
Deer J, Koska J, Ozias M, et al. (2015) Dietary models of insulin resistance. Metabolism 64: 163-171. doi: 10.1016/j.metabol.2014.08.013
![]() |
[46] | Otten J, Stomby A, Waling M, et al. (2017) Benefits of a Paleolithic diet with and without supervised exercise on fat mass, insulin sensitivity, and glycemic control: a randomized controlled trial in individuals with type 2 diabetes. Diabetes Metab Res Rev 33. |
[47] |
O'Keefe JH, Gheewala NM, O'Keefe JO (2008) Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 51: 249-255. doi: 10.1016/j.jacc.2007.10.016
![]() |
[48] |
Villareal DT, Aguirre L, Gurney AB, et al. (2017) Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults. N Engl J Med 376: 1943-1955. doi: 10.1056/NEJMoa1616338
![]() |
[49] |
Welch AA, MacGrego AJ, Minihane AM, et al. (2014) Dietary fat and fatty acid profile are associated with indices of skeletal muscle mass in women aged 18-79 years. J Nutr 144: 327-334. doi: 10.3945/jn.113.185256
![]() |
[50] |
Mickleborough TD (2013) Omega-3 polyunsaturated fatty acids in physical performance optimization. Int J Sport Nutr Exerc Metab 23: 83-96. doi: 10.1123/ijsnem.23.1.83
![]() |
[51] |
Aguilaniu B, Flore P, Perrault H, et al. (1995) Exercise-induced hypoxaemia in master athletes: effects of a polyunsaturated fatty acid diet. Eur J Appl Phytsiol Occup Physiol 72: 44-50. doi: 10.1007/BF00964113
![]() |
[52] |
Sureda A, Bibiloni MD, Martorell M, et al; PREDIMED Study Investigators. (2016) Mediterranean diets supplemented with virgin olive oil and nuts enhance plasmatic antioxidant capabilities and decrease xanthine oxidase activity in people with metabolic syndrome: The PREDIMED study. Mol Nutr Food Res 60: 2654-2664. doi: 10.1002/mnfr.201600450
![]() |
[53] |
Domínguez-Avila JA, Alvarez-Parrilla E, López-Díaz JA, et al. (2015) The pecan nut (Carya illinoinensis) and its oil and polyphenolic fractions differentially modulate lipid metabolism and the antioxidant enzyme activities in rats fed high-fat diets. Food Chem 168: 529-537. doi: 10.1016/j.foodchem.2014.07.092
![]() |
[54] |
Carey AN, Fisher DR, Joseph JA, et al. (2013) The ability of walnut extract and fatty acids to protect against the deleterious effects of oxidative stress and inflammation in hippocampal cells. Nutr Neurosci 16: 13-20. doi: 10.1179/1476830512Y.0000000023
![]() |
[55] |
Willis LM, Shukitt-Hale B, Cheng V, et al. (2009) Dose-dependent effects of walnuts on motor and cognitive function in aged rats. Br J Nutr 101: 1140-1144. doi: 10.1017/S0007114508059369
![]() |
[56] |
Liu Z, Wang W, Huang G, et al. (2016) In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus). J Sci Food Agric 96: 1836-1843. doi: 10.1002/jsfa.7604
![]() |
[57] |
Nagel JM, Brinkoetter M, Magkos F, et al. (2012) Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition 28: 67-75. doi: 10.1016/j.nut.2011.03.004
![]() |
1. | Zakaria Yaagoub, Karam Allali, Global Stability of Multi-Strain SEIR Epidemic Model with Vaccination Strategy, 2023, 28, 2297-8747, 9, 10.3390/mca28010009 |